Family · Pharmaceutical analytical standards
Dolutegravir
An antiretroviral integrase inhibitor, blocking the enzyme HIV uses to insert its genetic material into the host cell's DNA; approved in the United States in 2013 and in Europe in 2014. This family brings together the active ingredient, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?In 2019 the World Health Organization recommended it as both a first-line and a second-line treatment for all people living with HIV.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
